Daniel
Geffken

Get alertedif Daniel Geffken gets funded!
Daniel GeffkenAcusphere Inc - Strategic Advisor
Promedior Inc - Interim Chief Financial Officer
Usds Inc - Interim Chief Financial Officer
Genocea Biosciences Inc - Financial Consultant
Novira Therapeutics Inc - Executive Officer, Interim Chief Financial Officer
Infobionic Inc - Strategic Advisor
Alcobra Pharmaceuticals - Board of Directors; Audit Committee, Compensation Committee
Sideris Pharmaceuticals Inc - Chief Financial Officer
Lysosomal Therapeutics Inc - CFO
K2 Therapeutics Inc - Interim CFO
Synlogic - Executive Officer
Opsonix - Executive Officer
Deals involving Daniel Geffken
$2,500,000 raised with Acusphere Inc on February, 2012
$5,000,000 raised with Acusphere Inc on July, 2010
$3,000,000 raised with Promedior Inc on October, 2012
$21,759,050 raised with Promedior Inc on March, 2012
$6,500,000 raised with Promedior Inc on October, 2011
$12,000,000 raised with Promedior Inc on March, 2010
$6,000,000 raised with Promedior Inc on February, 2009
$4,578,466 raised with Usds Inc on May, 2013
$1,530,000 raised with Usds Inc on April, 2010
$30,500,000 raised with Genocea Biosciences Inc on July, 2013
$15,250,000 raised with Genocea Biosciences Inc on October, 2012
$30,000,000 raised with Genocea Biosciences Inc on October, 2012
$35,099,999 raised with Genocea Biosciences Inc on January, 2011
$27,995,233 raised with Novira Therapeutics Inc on February, 2014
$7,500,000 raised with Novira Therapeutics Inc on March, 2013
$23,000,000 raised with Novira Therapeutics Inc on August, 2012
$8,000,000 raised with Infobionic Inc on August, 2015
$17,000,000 raised with Infobionic Inc on November, 2014
$6,624,059 raised with Infobionic Inc on August, 2014
$17,000,000 raised with Infobionic Inc on April, 2014
$969,043 raised with Infobionic Inc on December, 2012
$26,000,000 raised with Alcobra Pharmaceuticals on February, 2015
$25,000,000 raised with Alcobra Pharmaceuticals on May, 2013
$32,000,000 raised with Sideris Pharmaceuticals Inc on October, 2013
$599,000 raised with Sideris Pharmaceuticals Inc on September, 2013
$6,000,000 raised with Lysosomal Therapeutics Inc on October, 2016
$20,000,000 raised with Lysosomal Therapeutics Inc on February, 2015
$4,842,033 raised with Lysosomal Therapeutics Inc on May, 2014
$30,300,000 raised with K2 Therapeutics Inc on June, 2014
$6,000,472 raised with K2 Therapeutics Inc on June, 2014
$42,000,000 raised with Synlogic on May, 2017
$40,000,000 raised with Synlogic on December, 2016
$17,116,500 raised with Synlogic on February, 2016
$40,000,000 raised with Synlogic on February, 2016
$5,000,000 raised with Synlogic on October, 2014
$4,000,000 raised with Synlogic on July, 2014
$8,000,000 raised with Opsonix on October, 2015
$4,000,000 raised with Opsonix on October, 2015
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check Daniel Geffken on Crunchbase.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!